In thinking about the economics around the launch of pharmaceutical products, it is useful to compare the situation to another area that has seen its economics evolve in recent years: space travel.

The pharmaceutical commercialization landscape is becoming increasingly complex. Tried and true paradigms for capturing market share and securing reimbursement must evolve in the face of demand for ...

We find ourselves in a brave, new world. While institutional market sectors such as entertainment and hospitality struggle, life sciences find comfort in the promise of a rowing therapeutic pipeline.

With the end of the pandemic approaching, B2B companies are looking at how commercialization practices were turned upside down in the past year and assessing what to keep vs. discard. There is a ...

Combined company offers next-generation commercialization model that directly connects life sciences to payers and patients to accelerate access, improve affordability and transform drug value across ...